11.2.210-11 · Infectious Disease and Immunity
Making Monoclonal Antibodies — Cambridge AS & A Level Biology 9700 Revision Notes & Topical Questions
5 min read 11 parts Lesson 16 of 21 1 quiz
Lesson summary
11.2.2 Making Monoclonal Antibodies — CAMBRIDGE AS & A LEVEL BIOLOGY 9700 — REVISION NOTES notes: Describe how monoclonal antibodies are produced from hybridoma cells and evaluate the technique.Polyclonal — when an animal is infected or immunised, many B cell clones respond becau…
- Plasma cells
- Myeloma cells
- Immunisation
- Purification
- Bioreactors
- Conditions
Part 1 of 9Monoclonal and polyclonal antibodies
Polyclonal
- Polyclonal when an animal is infected or immunised, many B cell clones respond because the antigen has several epitopes,
- giving a mixture of antibodies.
Monoclonal
- Monoclonal a population of identical antibodies made by a single clone of plasma cells, all binding the same epitope.
Value
- Value this uniform specificity makes them very useful in medicine and research.
Part 2 of 9The problem solved by hybridomas
Plasma cells
- Plasma cells they do not survive long in culture.
Myeloma cells
- Myeloma cells cancerous B cells divide indefinitely but do not make useful antibody.
Solution
- Solution the technique combines both properties.
Part 3 of 9Cell properties
| Cell | Property |
|---|---|
| B lymphocyte (plasma cell) | Makes one specific antibody but divides only a limited number of times in culture |
| Myeloma cell | Divides rapidly and indefinitely but does not make the required antibody |
| Hybridoma | Makes the specific antibody and divides indefinitely |
Part 4 of 9Production steps
1
Immunisation
- Immunisation inject a mouse with the antigen so its B cells make plasma cells.
- (for example a protein from a cancer cell or pathogen)
2
Isolation
- Isolation remove the spleen and collect B lymphocytes (plasma cells).
3
Fusion
- Fusion fuse the B cells with myeloma (tumour) cells using polyethylene glycol or an electric pulse to make hybridoma cells.
4
Selection
- Selection grow the mixture in a selective medium in which unfused myeloma cells and unfused B cells die.
5
Screening
- Screening separate hybridomas into individual wells and test the culture fluid of each for antibody that binds the antigen.
6
Cloning
- Cloning select a hybridoma making the correct antibody and grow it in large fermenters (or in mice).
7
Purification
- Purification harvest the antibody and purify it from the culture fluid.
Part 5 of 9Large-scale production
Bioreactors
- Bioreactors hybridomas grow under sterile conditions and antibody is secreted into the medium, so it can be collected continuously.
Purification
- Purification affinity chromatography passes the medium through a column carrying the antigen or an antibody-binding protein.
- Only antibodies of the required specificity remain and are later released.
Conditions
- Conditions a supply of nutrients and oxygen, a constant temperature (about 37 °C) and pH, and removal of waste.
Quality control
- Quality control each batch is tested to confirm that it binds only its target, and is pure and uncontaminated.
Part 6 of 9Why the antibodies are identical
Clone
- Clone all antibodies come from one clone, so they are genetically identical and bind exactly one epitope.
Mitosis
- Mitosis hybridomas divide by mitosis to give identical cells.
Cell roles
- B cells give specificity, myeloma cells give immortality, and the selective medium removes cells lacking both properties.
Part 7 of 9Humanised antibodies
Mouse antibodies
- Mouse antibodies they can cause an immune reaction in humans because they are recognised as foreign.
Humanised antibodies
- Humanised antibodies a mouse variable region is joined to a human constant region.
Fully human antibodies
- Fully human antibodies now produced by newer techniques.
Benefit
- Benefit they are safer and last longer in patients.
Part 8 of 9Evaluation
Advantages
- Advantages very high specificity, a constant supply of identical antibody and the ability to target any antigen.
Disadvantages
- Disadvantages the technique is complex and expensive, uses animals and may cause side effects or immune reaction.
- (ethical concerns)
Maintenance
- Maintenance the tumour-derived hybridoma line must be maintained carefully.
Part 9 of 9More from the specification
1Monoclonal antibody binding of toxins
- Monoclonal antibody binding of toxins hybridoma clones synthesize monospecific monoclonal antibodies engineered to bind and neutralize lethal bacterial toxins.
2Active vs Passive Immunity
- Active immunity develops when a person is exposed to foreign antigens on pathogen surfaces, stimulating clonal selection of B-cells and production of memory cells,
- whereas passive immunity provides rapid, short-term resistance through direct transfer of external antibodies into blood.
3Vaccines and Immunological Memory
- Vaccines introduce attenuated pathogens, toxoids,
- or isolated surface antigens, triggering a primary immune response and establishing long-lived memory B and T cells that protect against infectious disease.
4Monoclonal Antibody Production Method
- Monoclonal antibodies are produced by fusing isolated antigen-sensitised spleen B-lymphocytes with immortal myeloma cells to form hybridomas,
- which are screened and cultured to yield identical antibodies.
5Diagnostic and Therapeutic Targeting
- Because monoclonal antibodies bind with high specificity to a single unique epitope on a cell surface or circulating toxin, they are utilized to identify pathogen types, detect hCG in urine,
- and deliver targeted cancer treatments.
6Receptor protein
- Protein on the postsynaptic membrane that binds neurotransmitter.
7Vaccine
- Harmless antigen preparation that induces memory cells.
8Vaccination
- Introducing a weakened pathogen's antigens to produce memory cells.
9Disease
- A condition in which part of the body does not function properly.
10Toxin
- A poison released by bacteria.
11Active immunity
- Immunity from making your own antibodies and memory cells.
12Passive immunity
- Short-term immunity from antibodies given by another individual.
13Memory cell
- A lymphocyte that keeps instructions for making a specific antibody.
14Secondary response
- The rapid, large response on re-exposure to an antigen.
Key terms
| Term | Meaning |
|---|---|
| Monoclonal antibody | Identical antibodies from one clone, all binding the same epitope. |
| Polyclonal antibodies | A mixture of antibodies from many B cell clones. |
| Hybridoma | A fused plasma cell and myeloma cell that divides indefinitely and makes one antibody. |
| Myeloma cell | A cancerous B cell that divides indefinitely. |
| Selective medium | A culture medium in which only the wanted cells survive. |
| Humanised antibody | A mouse antibody modified to carry human constant regions. |
Avoid these mistakes
1
Saying plasma cells divide indefinitely in culture — they divide only a limited number of times.
2
Saying monoclonal antibodies come from many clones — they come from a single clone.
3
Saying unfused cells survive in the selective medium — they die.
4
Saying mouse antibodies are always safe in humans — they can cause an immune reaction.
Marked practiceQuizzes for this lesson
Last updated: